Genital Diseases, Female
Welcome,         Profile    Billing    Logout  
 271 Companies   374 Products   374 Products   160 Mechanisms of Action   34 Trials   5514 News 


«12...5253545556575859606162...110111»
  • ||||||||||  Trial completion, Preclinical, Enrollment change:  The Impact of Lifestyle Behavior on in Vitro Fertilization (IVF) Outcome (clinicaltrials.gov) -  Feb 3, 2015   
    P=N/A,  N=12800, Completed, 
    Recruiting --> Completed | N=40 --> 14 | Trial primary completion date: Jan 2015 --> Sep 2014 Enrolling by invitation --> Completed | N=2500 --> 12800
  • ||||||||||  birinapant (IGM-9427) / IGM Biosciences
    Trial primary completion date, Metastases:  Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (clinicaltrials.gov) -  Feb 3, 2015   
    P2,  N=11, Completed, 
    Enrolling by invitation --> Completed | N=2500 --> 12800 Trial primary completion date: Apr 2014 --> Dec 2013
  • ||||||||||  letrozole / Generic mfg., clomifene citrate / Generic mfg.
    Enrollment open:  COOL-COS: COmbining Oral Letrozole and Clomiphene for Ovarian Stimulation (clinicaltrials.gov) -  Feb 2, 2015   
    P4,  N=40, Enrolling by invitation, 
    Trial primary completion date: Apr 2014 --> Dec 2013 Not yet recruiting --> Enrolling by invitation
  • ||||||||||  Lynparza (olaparib) / Merck (MSD), AstraZeneca
    Enrollment closed, HEOR, Real-world evidence, BRCA Biomarker, Real-world:  OSCA - Olaparib Standard of CAre Study (clinicaltrials.gov) -  Feb 2, 2015   
    P=N/A,  N=2000, Active, not recruiting, 
    Not yet recruiting --> Enrolling by invitation Recruiting --> Active, not recruiting
  • ||||||||||  Zymafos (palifosfamide) / Alaunos Therap
    Trial primary completion date:  Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors (clinicaltrials.gov) -  Feb 2, 2015   
    P2,  N=20, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Sep 2014 --> Sep 2016
  • ||||||||||  Vigil (gemogenovatucel-T) / Gradalis
    Enrollment closed, Enrollment change, Trial primary completion date, Tumor cell:  Salvage Ovarian FANG (clinicaltrials.gov) -  Feb 2, 2015   
    P2,  N=1, Active, not recruiting, 
    Trial primary completion date: Sep 2014 --> Sep 2016 Recruiting --> Active, not recruiting | N=14 --> 1 | Trial primary completion date: Sep 2014 --> Jul 2015
  • ||||||||||  Enrollment closed:  Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia (clinicaltrials.gov) -  Jan 30, 2015   
    P=N/A,  N=114, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Jan 2015 Recruiting --> Active, not recruiting
  • ||||||||||  Trial primary completion date:  3DRCT: Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? (clinicaltrials.gov) -  Jan 28, 2015   
    P1,  N=42, Recruiting, 
    Not yet recruiting --> Recruiting | N=43 --> 25 | Initiation date: Jun 2014 --> Jan 2015 Trial primary completion date: Jun 2015 --> Dec 2015
  • ||||||||||  Norditropin (somatropin) / Novo Nordisk
    Trial completion, Enrollment change:  Microflare Protocol in Poor Responders (clinicaltrials.gov) -  Jan 28, 2015   
    P4,  N=145, Completed, 
    Trial primary completion date: Oct 2014 --> Oct 2015 Recruiting --> Completed | N=198 --> 145
  • ||||||||||  Enrollment open, Trial primary completion date:  MecillinamCT: Mecillinam for Treatment of Genital Chlamydia Infection (clinicaltrials.gov) -  Jan 26, 2015   
    P2,  N=50, Recruiting, 
    N=67 --> 1 | Recruiting --> Terminated Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2014 --> Apr 2015
  • ||||||||||  Biomarker, Enrollment closed, Preclinical:  Next Generation Sequencing Screening for Embryonic Ploidy Status (clinicaltrials.gov) -  Jan 26, 2015   
    P=N/A,  N=250, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2014 --> Apr 2015 Recruiting --> Active, not recruiting
  • ||||||||||  Enrollment closed, Preclinical:  Sequential vs. Monophasic Media Impact Trial (SuMMIT) (clinicaltrials.gov) -  Jan 26, 2015   
    P4,  N=200, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  veliparib (ABT-888) / AbbVie
    Trial primary completion date, Combination therapy, BRCA Biomarker, PARP Biomarker:  Phase II ABT-888 With Cyclophosphamide (clinicaltrials.gov) -  Jan 26, 2015   
    P2,  N=29, Active, not recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: May 2015 --> Dec 2014
  • ||||||||||  Cycloset (bromocriptine) / Bausch Health
    Enrollment closed, Trial primary completion date:  Vaginal Bromocriptine for Treatment of Adenomyosis (clinicaltrials.gov) -  Jan 22, 2015   
    P1,  N=33, Active, not recruiting, 
    Enrolling by invitation --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Mar 2017
  • ||||||||||  Baxdela (delafloxacin) / Menarini, Melinta Therap
    Enrollment change, Trial termination:  Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea (clinicaltrials.gov) -  Jan 20, 2015   
    P3,  N=460, Terminated, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Mar 2017 N=757 --> 460 | Active, not recruiting --> Terminated
  • ||||||||||  cabergoline / Generic mfg.
    Enrollment change, Trial primary completion date:  Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) -  Jan 20, 2015   
    P3,  N=300, Recruiting, 
    N=757 --> 460 | Active, not recruiting --> Terminated N=200 --> 300 | Trial primary completion date: Jun 2014 --> Mar 2015
  • ||||||||||  Phase classification:  Ultrasound and Endometrial Hyperplasia (clinicaltrials.gov) -  Jan 20, 2015   
    P=N/A,  N=36, Terminated, 
    N=200 --> 300 | Trial primary completion date: Jun 2014 --> Mar 2015 Phase classification: P1/2 --> P=N/A
  • ||||||||||  Trial primary completion date, HEOR:  Internet-based System for Cancer Patients to Self-report Toxicity (clinicaltrials.gov) -  Jan 20, 2015   
    P=N/A,  N=1007, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015